05/23/2002 1:45 Kresge
Rebecca M. Henderson, '81, Eastman Kodak LFM Professor of Management; Darlene Solomon, PhD '85, Director of the Life Science Technologies Laboratory, Agilent Technologies ; Jose B. Cibelli, Vice-President of Research, A.C.T. Group ; Benjamin Cravatt, Sripps Research Institute ; David Sabatini, Whitehead Institute for Biomedical Research ;

Description: We've deciphered the human genome and moved into proteomics-the study of the individual proteins that the genes code for. Such advances anticipate the day when drugs are not only targeted at molecular workings or specific diseases but tailor-made for each individual's genetic makeup.

Host(s): Office of the Provost, Technology Review